4//SEC Filing
Raptor Pharmaceutical Corp 4
Accession 0001140361-16-083649
CIK 0001070698operating
Filed
Oct 25, 8:00 PM ET
Accepted
Oct 26, 4:39 PM ET
Size
9.7 KB
Accession
0001140361-16-083649
Insider Transaction Report
Form 4
Lapointe Gregg Anthony
Director
Transactions
- Disposition to Issuer
Common Stock
2016-10-25$9.00/sh−8,330$74,970→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2016-10-25−7,915→ 0 totalExercise: $5.22Exp: 2026-04-15→ Common Stock (7,915 underlying) - Disposition from Tender
Common Stock
2016-10-24$9.00/sh−2,092$18,828→ 8,330 total
Footnotes (3)
- [F1]Shares tendered in connection with an offer to purchase all of the issued and outstanding shares of common stock of Raptor Pharmaceutical Corp. ("Raptor"), par value $0.001 per share, for an amount of $9.00 per share in cash, without interest and less any applicable withholding taxes, commenced pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of September 12, 2016, by and among Raptor, Horizon Pharma plc, a public limited company organized under the laws of Ireland ("Parent") and Misneach Corporation, a Delaware corporation and an indirect wholly owned subsidiary of Parent.
- [F2]Pursuant to the Merger Agreement, on October 25, 2016, each outstanding restricted stock unit was accelerated in full and cancelled in exchange for the right to receive $9.00 per share in cash, without interest and less any required withholding taxes.
- [F3]Pursuant to the Merger Agreement, on October 25, 2016, each outstanding stock option was accelerated in full and cancelled in exchange for the right to receive $9.00 in cash, without interest and less the exercise price of such option and any required withholding taxes.
Documents
Issuer
Raptor Pharmaceutical Corp
CIK 0001070698
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070698
Filing Metadata
- Form type
- 4
- Filed
- Oct 25, 8:00 PM ET
- Accepted
- Oct 26, 4:39 PM ET
- Size
- 9.7 KB